REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 70 filers reported holding REPARE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,713 | -90.9% | 519 | -86.9% | 0.00% | – |
| Q1 2024 | $18,727 | +1182.7% | 3,976 | +1888.0% | 0.00% | – |
| Q4 2023 | $1,460 | -98.0% | 200 | -96.7% | 0.00% | -100.0% |
| Q3 2023 | $74,002 | +214.1% | 6,126 | +175.1% | 0.00% | +100.0% |
| Q2 2023 | $23,562 | +21127.0% | 2,227 | -80.3% | 0.00% | -75.0% |
| Q1 2023 | $111 | +326.9% | 11,316 | +533.2% | 0.00% | +300.0% |
| Q4 2022 | $26 | -100.0% | 1,787 | -80.9% | 0.00% | -50.0% |
| Q3 2022 | $113,000 | +61.4% | 9,335 | +90.2% | 0.00% | +100.0% |
| Q1 2022 | $70,000 | – | 4,909 | +44527.3% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 11 | -94.4% | 0.00% | – |
| Q3 2021 | $5,000 | -95.5% | 196 | -94.5% | 0.00% | -100.0% |
| Q2 2021 | $110,000 | +12.2% | 3,536 | +9.6% | 0.00% | +50.0% |
| Q1 2021 | $98,000 | +58.1% | 3,225 | +78.6% | 0.00% | 0.0% |
| Q4 2020 | $62,000 | – | 1,806 | +90200.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 2 | -99.8% | 0.00% | -100.0% |
| Q2 2020 | $27,000 | – | 873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $32,989,176 | 13.80% |
| CHI Advisors LLC | 2,800,126 | $41,189,854 | 10.97% |
| MPM BioImpact LLC | 1,639,849 | $24,122,179 | 6.26% |
| BVF INC/IL | 8,291,988 | $121,975,143 | 5.15% |
| Deep Track Capital, LP | 2,727,606 | $40,123,084 | 1.68% |
| Redmile Group, LLC | 2,684,396 | $39,487,465 | 1.62% |
| HighVista Strategies LLC | 164,890 | $2,425,532 | 1.44% |
| Orbimed Advisors | 3,322,488 | $48,873,798 | 0.94% |
| Artal Group S.A. | 700,000 | $10,297 | 0.58% |
| HARBOR CAPITAL ADVISORS, INC. | 34,572 | $508,554 | 0.49% |